News

News
|
NPR

5 Years After Indiana's Historic HIV Outbreak, Many Rural Places Remain At Risk

One Small Town Rebounds After An HIV Outbreak, Yet Rural HIV Risk Remains High

5 Years After Indiana's Historic HIV Outbreak, Many Rural Places Remain At Risk
|
CNBC

Life under quarantine: Civil rights activists criticize ‘unprecedented’ coronavirus lockdowns

Professor of Law and Faculty Director of the Global Health Justice Partnership Amy Kapczynski ’03 is quoted in a CNBC story about quarantines for patients suspected of having the coronavirus.

Life under quarantine: Civil rights activists criticize ‘unprecedented’ coronavirus lockdowns
Dutee Chand and Caster Semenya

An Interdisciplinary Conversation on Gender Rights, Race, and Sports

On October 3, 2019, panelists at Yale Law School discussed the implications of gendered and racialized sports eligibility requirements on athletes’ bodily autonomy and rights.
An Interdisciplinary Conversation on Gender Rights, Race, and Sports
|
FiercePharma

Gilead schemed with J&J, Bristol-Myers to keep their HIV combo monopoly, lawsuit claims

Gilead Sciences used its monopoly on one critical component in HIV combo meds to stifle generic competition and keep prices high, a new lawsuit claims—and the Big Biotech did so with the help of combo partners Johnson & Johnson and Bristol-Myers Squibb.

Gilead schemed with J&J, Bristol-Myers to keep their HIV combo monopoly, lawsuit claims
|
The Washington Post

Gilead is accused of cutting anti-competitive deals to extend profit on HIV drug combinations

Gilead forged deals that blocked generic competition, even after Gilead’s brand patents on key medications in the combination pills expired, according to the civil antitrust lawsuit brought in U.S. District Court in San Francisco by HIV/AIDS activists and two service unions.

Gilead is accused of cutting anti-competitive deals to extend profit on HIV drug combinations
An exterior shot of one of the entrances into the Sterling Law Building.

GHJP Finds Incarceration for Low-Level Drug Crimes Rapidly Spreading TB in Brazil

A new report from the Yale Global Health Justice Partnership (GHJP) at the Yale Law School and the Yale School of Public Health finds that Increasing rates of drug-related incarcerations are perpetuating tuberculosis (TB) infection among Brazil’s general population.
GHJP Finds Incarceration for Low-Level Drug Crimes Rapidly Spreading TB in Brazil
|
The New York Times

Gregg Gonsalves Blends Activism and Science

The New York Times profiles Gregg Gonsalves, co-director of the Global Health Justice Partnership (GHJP).

Gregg Gonsalves Blends Activism and Science
solomon-medicare-for-all-carousel-pic.jpg

Solomon Center Hosts Rep. DeLauro to Discuss Universal Health Care

On March 20, 2019 the Solomon Center for Health Law and Policy at Yale Law School hosted a discussion on U.S. Representative Rosa DeLauro’s proposed Medicare for America (MFA) plan.
Solomon Center Hosts Rep. DeLauro to Discuss Universal Health Care
View of YLS building and stonework owl

GHJP Joins PrEP4All in Calling on CDC To Use Its Patents for PrEP

The Yale Global Health Justice Partnership (GHJP) joined the PrEP4All Collaboration (PrEP4All) in calling on the Centers for Disease Control and Prevention (CDC) to use its patents on HIV pre-exposure prophylaxis (PrEP) to promote universal access to PrEP within the United States.
GHJP Joins PrEP4All in Calling on CDC To Use Its Patents for PrEP
|
The Washington Post

An HIV treatment cost taxpayers millions. The government patented it. But a pharma giant is making billions.

Christopher J. Morten, a fellow at the Global Health Justice Partnership, is quoted in an article about a drug manufacturer profiting from an HIV prevention treatment paid for and patented by the government. 

An HIV treatment cost taxpayers millions. The government patented it. But a pharma giant is making billions.